CN101878226B - 精氨酸取代的新型合成肽及其应用 - Google Patents

精氨酸取代的新型合成肽及其应用 Download PDF

Info

Publication number
CN101878226B
CN101878226B CN200880114504.9A CN200880114504A CN101878226B CN 101878226 B CN101878226 B CN 101878226B CN 200880114504 A CN200880114504 A CN 200880114504A CN 101878226 B CN101878226 B CN 101878226B
Authority
CN
China
Prior art keywords
arg
lys
gln
ser
ala
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CN200880114504.9A
Other languages
English (en)
Chinese (zh)
Other versions
CN101878226A (zh
Inventor
I·马特斯贝-巴尔策
G·多尔芬
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
PharmaSurgics in Sweden AB
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CN101878226A publication Critical patent/CN101878226A/zh
Application granted granted Critical
Publication of CN101878226B publication Critical patent/CN101878226B/zh
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/79—Transferrins, e.g. lactoferrins, ovotransferrins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pain & Pain Management (AREA)
  • Toxicology (AREA)
  • Dermatology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Oncology (AREA)
  • Rheumatology (AREA)
  • Communicable Diseases (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
CN200880114504.9A 2007-11-14 2008-11-10 精氨酸取代的新型合成肽及其应用 Expired - Fee Related CN101878226B (zh)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
EP07120713A EP2060586A1 (en) 2007-11-14 2007-11-14 New synthetic arginine substituted peptides and their use
EP07120713.8 2007-11-14
US99006607P 2007-11-26 2007-11-26
US60/990,066 2007-11-26
PCT/EP2008/065186 WO2009062898A1 (en) 2007-11-14 2008-11-10 New synthetic arginine substituted peptides and their use

Publications (2)

Publication Number Publication Date
CN101878226A CN101878226A (zh) 2010-11-03
CN101878226B true CN101878226B (zh) 2014-06-25

Family

ID=39226731

Family Applications (1)

Application Number Title Priority Date Filing Date
CN200880114504.9A Expired - Fee Related CN101878226B (zh) 2007-11-14 2008-11-10 精氨酸取代的新型合成肽及其应用

Country Status (9)

Country Link
US (2) US7928185B2 (enExample)
EP (2) EP2060586A1 (enExample)
JP (1) JP2011503137A (enExample)
CN (1) CN101878226B (enExample)
AU (1) AU2008323041A1 (enExample)
CA (1) CA2703894A1 (enExample)
DK (1) DK2212352T3 (enExample)
MX (1) MX2010005280A (enExample)
WO (1) WO2009062898A1 (enExample)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2481751A1 (en) 2011-01-26 2012-08-01 PharmaSurgics in Sweden AB Human lactoferrin derived peptides
WO2014090905A1 (en) * 2012-12-11 2014-06-19 Imaxio Modified coiled coil type proteins having improved properties
JP2016520534A (ja) 2013-03-18 2016-07-14 イマクシオＩｍａｘｉｏ インフルエンザ核タンパク質ワクチン
US9850278B2 (en) 2013-04-25 2017-12-26 Carmel-Haifa University Economic Corp. Synthetic anti-inflammatory peptides and use thereof
US12295990B2 (en) 2018-11-09 2025-05-13 The Wistar Institute Of Anatomy And Biology Use of lactoferrin for generating myeloid-derived suppressor cells

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1362969A (zh) * 1999-02-05 2002-08-07 埃吉尼克斯股份有限公司 抗微生物/中和内毒素的多肽

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2818056B2 (ja) 1990-09-07 1998-10-30 森永乳業株式会社 抗菌性ペプチドおよび抗菌剤
US5656591A (en) 1992-01-23 1997-08-12 Morinaga Milk Industry Co., Ltd. Antimicrobial agents and method for treating products therewith
JP3347819B2 (ja) 1993-06-28 2002-11-20 森永乳業株式会社 抗菌性ペプチドの精製方法
JP3529423B2 (ja) 1994-04-01 2004-05-24 森永乳業株式会社 抗菌性ペプチドの製造方法
JP3812957B2 (ja) 1994-08-02 2006-08-23 森永乳業株式会社 角膜損傷治療剤
JPH08143468A (ja) 1994-11-17 1996-06-04 Morinaga Milk Ind Co Ltd 抗潰瘍剤
JP2001504447A (ja) 1996-08-12 2001-04-03 エイプラス サイエンス インベスト アーベー ラクトフェリンおよび／またはラクトフェリシンでの、感染、炎症および／または腫瘍の処置および予防
SE9804614A0 (en) * 1998-07-06 2000-01-07 A+ Science Invest Ab New peptides and use thereof
CA2388910C (en) * 1999-11-11 2008-10-07 Am-Pharma B.V. Antimicrobial activity of the first cationic cluster of human lactoferrin
US7183381B2 (en) 2004-10-26 2007-02-27 Agennix, Inc. Composition of lactoferrin related peptides and uses thereof

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1362969A (zh) * 1999-02-05 2002-08-07 埃吉尼克斯股份有限公司 抗微生物/中和内毒素的多肽

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
E.W.Odell,et al.Antibacterial activity of peptides homologous to a loop region in human lactoferrin.《FEBS letters》.1996,第382卷175-178. *
P.H.C.van Berkel,et al.N-terminal stretch Arg2,Arg3,Arg4 and Arg5 of human lactoferrin is essential for binding to heparin,bacterial lipopolysaccharide,human lysozyme and DNA.《Biochemical Journal》.1997,第328卷145-151. *

Also Published As

Publication number Publication date
DK2212352T3 (da) 2014-09-29
EP2212352A1 (en) 2010-08-04
CN101878226A (zh) 2010-11-03
US20090186823A1 (en) 2009-07-23
US8815812B2 (en) 2014-08-26
MX2010005280A (es) 2010-08-31
CA2703894A1 (en) 2009-05-22
EP2060586A1 (en) 2009-05-20
AU2008323041A1 (en) 2009-05-22
US7928185B2 (en) 2011-04-19
US20110224152A1 (en) 2011-09-15
WO2009062898A1 (en) 2009-05-22
JP2011503137A (ja) 2011-01-27
EP2212352B1 (en) 2014-07-02

Similar Documents

Publication Publication Date Title
JP2009526045A (ja) 新規抗菌ペプチド及びその使用
KR20090027213A (ko) 개선된 항미생물성 펩타이드
KR101949210B1 (ko) 항염증 활성을 가진 인간 락토페린계 펩타이드
JP4611979B2 (ja) ヘパリン結合活性を有する新規な抗微生物ペプチド
CN101878226B (zh) 精氨酸取代的新型合成肽及其应用
AU2012210564A1 (en) Human lactoferrin based peptides having antiinflammatory activity
US20110053833A1 (en) Synthetic peptides and their use
CN101448851B (zh) 改进的抗微生物肽
HK1149769A (en) New synthetic arginine substituted peptides and their use
CN113226349A (zh) 抗微生物肽及其使用方法
WO2013023166A2 (en) Hapivirins and diprovirins

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
CI01 Publication of corrected invention patent application

Correction item: Inventor

Correct: PHARMASURGICS IN SWEDEN AB|Dolphin Gunnar

False: Mattsby-baltzer Inger|Dolphin Gunnar

Number: 44

Volume: 26

CI02 Correction of invention patent application

Correction item: Inventor

Correct: PHARMASURGICS IN SWEDEN AB|Dolphin Gunnar

False: Mattsby-baltzer Inger|Dolphin Gunnar

Number: 44

Page: The title page

Volume: 26

ERR Gazette correction

Free format text: CORRECT: INVENTOR; FROM: MATTSBY-BALTZER; DOLPHIN GUNNAR TO: MATTSBY-BALTZER INGER; DOLPHIN GUNNAR

REG Reference to a national code

Ref country code: HK

Ref legal event code: DE

Ref document number: 1149769

Country of ref document: HK

ASS Succession or assignment of patent right

Owner name: PEGAMA COMPANY

Free format text: FORMER OWNER: PHARMASURGICS IN SWEDEN AB

Effective date: 20121116

C41 Transfer of patent application or patent right or utility model
TA01 Transfer of patent application right

Effective date of registration: 20121116

Address after: Solna, Sweden

Applicant after: PharmaSurgics in Sweden AB

Address before: Gothenburg

Applicant before: Pharmasurgics In Sweden AB

ASS Succession or assignment of patent right

Owner name: MATTSBY-BALTZER INGER

Free format text: FORMER OWNER: PERGAMA COMPANY

Effective date: 20131017

C41 Transfer of patent application or patent right or utility model
TA01 Transfer of patent application right

Effective date of registration: 20131017

Address after: Gothenburg

Applicant after: PHARMASURGICS IN SWEDEN AB

Address before: Solna, Sweden

Applicant before: PharmaSurgics In Sweden AB

C14 Grant of patent or utility model
GR01 Patent grant
REG Reference to a national code

Ref country code: HK

Ref legal event code: WD

Ref document number: 1149769

Country of ref document: HK

CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20140625

Termination date: 20211110

CF01 Termination of patent right due to non-payment of annual fee